Patient groups invest in genetic databases to speed drug development

Tens of millions of dollars are being invested by nonprofit patient groups, including the Leukemia & Lymphoma Society, the Multiple Myeloma Research Foundation and the Michael J. Fox Foundation, to create genetic databases in a push to support clinical studies and accelerate drug development. Drugmakers and scholars can analyze genetic mutations using material from these databases, which are created to gather DNA and other data from patients with hard-to-treat diseases. With the aid of these databases, patients familiar with their own genetic mutations can find information about clinical studies.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA